CVRx (CVRX)
(Delayed Data from NSDQ)
$8.73 USD
+0.39 (4.68%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $8.72 -0.01 (-0.11%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth F Momentum F VGM
Income Statements
Fiscal Year end for CVRx, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 39 | 22 | 13 | 6 | NA |
Cost Of Goods | 6 | 5 | 4 | 1 | NA |
Gross Profit | 33 | 17 | 9 | 5 | NA |
Selling & Adminstrative & Depr. & Amort Expenses | 76 | 60 | 35 | 16 | 0 |
Income After Depreciation & Amortization | -43 | -43 | -26 | -12 | 0 |
Non-Operating Income | 4 | 1 | -15 | 0 | NA |
Interest Expense | 2 | 0 | 2 | 2 | NA |
Pretax Income | -41 | -41 | -43 | -14 | NA |
Income Taxes | 0 | 0 | 0 | 0 | NA |
Minority Interest | 0 | 0 | 0 | 0 | NA |
Investment Gains/Losses | 0 | 0 | 0 | 0 | NA |
Other Income/Charges | 0 | 0 | 0 | 0 | NA |
Income From Cont. Operations | -41 | -41 | -43 | -14 | NA |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | NA |
Net Income (GAAP) | -41 | -41 | -43 | -14 | NA |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -42 | -42 | -26 | -11 | 0 |
Depreciation & Amortization (Cash Flow) | 1 | 0 | 0 | 0 | NA |
Income After Depreciation & Amortization | -43 | -43 | -26 | -12 | 0 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 20.75 | 20.53 | 10.36 | NA | NA |
Diluted EPS Before Non-Recurring Items | -1.99 | -2.02 | -4.16 | NA | NA |
Diluted Net EPS (GAAP) | -1.99 | -2.02 | -4.16 | NA | NA |
Fiscal Year end for CVRx, Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 11.81 | 10.77 | 11.31 | 10.51 | 9.50 |
Cost Of Goods | 1.90 | 1.62 | 1.72 | 1.69 | 1.52 |
Gross Profit | 9.91 | 9.16 | 9.58 | 8.82 | 7.98 |
SG&A, R&D, and Dept/Amort Expenses | 23.89 | 31.39 | 19.25 | 18.35 | 19.74 |
Income After SG&A, R&D, and Dept/Amort Expenses | -13.98 | -22.23 | -9.67 | -9.53 | -11.76 |
Non-Operating Income | 0.94 | 1.04 | 1.12 | 1.06 | 0.62 |
Interest Expense | 0.96 | 0.96 | 0.58 | 0.50 | 0.48 |
Pretax Income | -13.99 | -22.15 | -9.12 | -8.97 | -11.62 |
Income Taxes | 0.04 | 0.04 | 0.04 | 0.04 | 0.03 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -14.03 | -22.19 | -9.16 | -9.01 | -11.65 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -14.03 | -22.19 | -9.16 | -9.01 | -11.65 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 21.63 | 21.23 | 20.83 | 20.80 | 20.71 |
Diluted EPS Before Non-Recurring Items | -0.65 | -1.04 | -0.44 | -0.43 | -0.56 |
Diluted Net EPS (GAAP) | -0.65 | -1.04 | -0.45 | -0.43 | -0.56 |